Synlogic (SYBX) News Today $1.67 -0.01 (-0.60%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 27 at 4:32 AM | americanbankingnews.comSynlogic (NASDAQ:SYBX) Stock Crosses Above Fifty Day Moving Average of $1.57July 21, 2024 | wsj.comSynlogic Inc.July 21, 2024 | morningstar.comSynlogic Inc SYBXMay 23, 2024 | investorplace.comThe Summer Stock Exodus: 3 Companies to Ditch Before the Heat HitsMay 16, 2024 | markets.businessinsider.comHold Rating Maintained for Synlogic Amidst Setbacks and Financial UncertaintiesMay 14, 2024 | investorplace.comSYBX Stock Earnings: Synlogic Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Reports First Quarter 2024 Financial ResultsMay 14, 2024 | baystreet.caSynlogic Flat on Q1 NumbersMay 14, 2024 | globenewswire.comSynlogic Reports First Quarter 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comWe Think Synlogic (NASDAQ:SYBX) Needs To Drive Business Growth CarefullyApril 16, 2024 | finance.yahoo.comSynlogic, Inc. (SYBX)April 6, 2024 | investing.comSynlogic's head of finance sells shares worth $325March 21, 2024 | markets.businessinsider.comHold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic UncertaintiesMarch 19, 2024 | globenewswire.comSynlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | finance.yahoo.comSynlogic Adopts Limited Duration Stockholders Rights PlanFebruary 20, 2024 | globenewswire.comSynlogic Adopts Limited Duration Stockholders Rights PlanFebruary 13, 2024 | markets.businessinsider.comHold Rating on Synlogic Amid Discontinued Lead Program and Reduced Price TargetFebruary 9, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 9, 2024 | in.investing.comSynlogic plunges as it ceases operations following decision to discontinue Synpheny-3 studyFebruary 9, 2024 | realmoney.thestreet.comSynlogic just downgraded at Chardan, here's whyFebruary 9, 2024 | msn.comRare Disease Focused-Synlogic Pulls Plug On Lead Program, Shares NosediveFebruary 9, 2024 | bizjournals.comSynlogic cuts most workers after halting rare disease drug trialFebruary 9, 2024 | msn.comSynlogic shares crater amid company shut down, failed drug studyFebruary 9, 2024 | msn.comWhy Is Synlogic (SYBX) Stock Down 55% Today?February 9, 2024 | investorplace.comWhy Is Synlogic (SYBX) Stock Down 55% Today?February 8, 2024 | marketwatch.comSynlogic to Cease Operations, Cut Almost All Employees After Ending TrialFebruary 8, 2024 | marketwatch.comSynlogic Shares Tumble 55% on Discontinued Trial, Halt to OperationsFebruary 8, 2024 | msn.comSynlogic to discontinue lead drug program, cease operationsFebruary 8, 2024 | finance.yahoo.comSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 8, 2024 | finance.yahoo.comSynlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateFebruary 8, 2024 | marketbeat.comTrading was temporarily halted for "SYBX" at 04:02 PM with a stated reason of "News pending."February 6, 2024 | ca.finance.yahoo.comSynlogic Inc (MIN.MU)February 3, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaFebruary 2, 2024 | finance.yahoo.comSynlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaJanuary 17, 2024 | benzinga.comSynlogic Stock (NASDAQ:SYBX) Dividends: History, Yield and DatesJanuary 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), Enanta Pharmaceuticals (ENTA) and Synlogic (SYBX)January 6, 2024 | markets.businessinsider.comOptimistic Outlook for Synlogic’s Growth Potential and Financial SustainabilityJanuary 4, 2024 | finanznachrichten.deSynlogic, Inc.: Synlogic Provides Corporate Update and Outlook for 2024January 4, 2024 | msn.comSynlogic provides corporate update, outlook for 2024January 4, 2024 | finance.yahoo.comSynlogic Provides Corporate Update and Outlook for 2024December 27, 2023 | finanznachrichten.deSynlogic, Inc.: Synlogic Announces Contract with the Air Force Research LabDecember 27, 2023 | msn.comSynlogic bags contract to develop live probiotic productsDecember 27, 2023 | markets.businessinsider.comSynlogic Secures $1 Mln Subcontract Under Air Force Research LabDecember 27, 2023 | finance.yahoo.comSynlogic Announces Contract with the Air Force Research LabDecember 13, 2023 | benzinga.comSynlogic Stock (NASDAQ:SYBX), Analyst Ratings, Price Targets, PredictionsDecember 7, 2023 | finance.yahoo.comSynlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023November 13, 2023 | markets.businessinsider.comProgressive Synpheny-3 Trial and Extended Patent Protection Propel Buy Rating for SynlogicNovember 11, 2023 | markets.businessinsider.comSynlogic’s Financial Strength and Promising Clinical Trials Bolster Buy RatingNovember 9, 2023 | benzinga.comSynlogic: Q3 Earnings InsightsNovember 9, 2023 | finance.yahoo.comSynlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here SYBX Media Mentions By Week SYBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYBX News Sentiment▼0.220.62▲Average Medical News Sentiment SYBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYBX Articles This Week▼41▲SYBX Articles Average Week Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theratechnologies News Today Connect Biopharma News Today MediciNova News Today Aileron Therapeutics News Today SELLAS Life Sciences Group News Today Hookipa Pharma News Today BioLineRx News Today Eledon Pharmaceuticals News Today Rockwell Medical News Today Eyenovia News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SYBX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synlogic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.